Fraunhofer Institute for Interfacial Engineering and Biotechnology

The Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB develops and optimizes processes, technologies, and products for health, sustainable chemistry and the environment. In doing so, we rely on the unique combination of expertise in biology and the engineering sciences in order to contribute to human welfare, a sustainable economy, and an intact environment with the systems approach of bioeconomy as well as bioinspired, biointegrated and biointelligent solutions. Working closely with partners from universities and industry, the IGB covers the entire innovation chain from fundamental research to industrial implementation. We provide our customers with research services ranging from feasibility studies...

Biotechnologie,grenzflächentechnologie,grenzflächenverfahrenstechnik,materialwissenschaft,molekulare biotechnologie,physikalische prozesstechnik,umweltbiotechnologie,bioverfahrenstechnik,abwasserreinigung,industrielle biotechnologie,nanotechnologie,medizintechnik,prozesstechnik,verfahrenstechnik,and organ-on-a-chip

Fraunhofer institute for interfacial engineering and biotechnology operates in the Research services industry.

Fraunhofer institute for interfacial engineering and biotechnology's revenue is 11m - 100m

Fraunhofer institute for interfacial engineering and biotechnology has 201 - 500 employees.